Siegfried (SFZN.SW)

Siegfried stock price today, ATLAS forecast and fair value

Healthcare · Drug Manufacturers - Specialty & Generic · SIX Swiss Exchange · Switzerland

CHF 74.00▲ +1.16%

Prices as of Oct 26, 2026 · CHF

ATLAS fair value

CHF 137.29

Below fair value · 46% discount

Chance of rising in 1 month

52%

that it ends higher than today in 21 sessions

0%coin flip 50%100%

This is just the summary. See everything on Siegfried in ATLAS

ATLAS's own quantitative analysis, all in one place.

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
See everything included
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.

On Siegfried

  • Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
  • Officers and shareholdersWho runs the company and which funds hold its shares.
  • Customer and supplier mapWho it does business with, from its own filings.
  • Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
  • NewsThe latest on the company, in one place.

And for you

  • ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
  • AlertsWe let you know when something changes in your stocks.
  • Crisis simulatorHow your portfolio would do in a crash like 2008.
  • Practice risk-free$10,000 in virtual money to invest at real prices.
  • Global screenerSearch US stocks and stocks from 47 countries with filters.
Get started →

Plans from €3.99 a month.

ATLAS estimates Siegfried's fair value at about CHF 137.29 per share (reasonable range: CHF 116.70 to CHF 157.88). At CHF 74.00, the stock trades 46% below it.

It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.

ATLAS's model gives Siegfried a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.

In half of the simulated outcomes the price ends between CHF 70.80 and CHF 77.77; in 9 out of 10, between CHF 65.14 and CHF 84.53. Estimated annual volatility is 27%.

Price, last 12 months (weekly close)

Siegfried (SFZN.SW) — Price, last 12 months (weekly close)Oct 24, 2025: CHF 81.30. Oct 26, 2026: CHF 74.00. ▼CHF 96.30CHF 67.50Oct 24, 2025Oct 26, 2026

Key numbers

Market cap
CHF 3.1B
Market cap (USD)
$3.7B
P/E ratio
18.3
Dividend yield
0.56%
52-week high
CHF 101.60
52-week low
CHF 65.05
Revenue (12 months)
CHF 1.3B
Gross margin
27.0%
Operating margin
14.1%
Net margin
12.8%
Beta
0.79

What this means

These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Siegfried sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.

Over the last 52 weeks SFZN.SW has traded between CHF 65.05 and CHF 101.60. Today it is 27.2% below that high and 14% above its low.

On the business: net margin is 12.8%; it trades at 18.3 times earnings.

Its beta is 0.79: it tends to move less than the market.

About the company

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including exclusive synthesis that manufactures custom APIs.

Want to see everything about Siegfried?

Get started →

Plans from €3.99 a month.

Comparable companies

Other companies in the same line of business:

Frequently asked questions

What is Siegfried (SFZN.SW) fair value?

About CHF 137.29 per share according to ATLAS (reasonable range: CHF 116.70 to CHF 157.88). With the stock at CHF 74.00, it is 46% below it.

What is the chance SFZN.SW goes up next month?

52%: close to a coin flip. In half of the simulated outcomes, SFZN.SW ends the month between CHF 70.80 and CHF 77.77.

How big is Siegfried and what is its P/E ratio?

Siegfried's market capitalization is CHF 3.1B. Its price-to-earnings (P/E) ratio is 18.3: you pay CHF 18.3 for each CHF 1.00 of yearly earnings.

Does Siegfried pay a dividend?

Yes. SFZN.SW's current dividend yield is 0.56% at today's price (CHF 74.00).

Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy